PTX3 as a diagnostic and prognostic biomarker in lung adenocarcinoma: a comprehensive analysis
Abstract Background Lung cancer remains a leading global cause of mortality, with lung adenocarcinoma (LUAD) as the predominant histological subtype. Current serum biomarkers like carcinoembryonic antigen (CEA) lack specificity, necessitating novel diagnostic targets. Pentraxin 3 (PTX3), a homo-mult...
Saved in:
| Main Authors: | Shaobo Zhou, Na Li, Dina Haishaer, Hongmei Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02983-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression of the IL-18-related gene PTX3 correlates with clinicopathological features and prognosis in glioma patients
by: Delin Wang, et al.
Published: (2025-07-01) -
Advances in understanding the role of pentraxin-3 in lung infections
by: Li Ma, et al.
Published: (2025-04-01) -
GPC3 as a potential diagnostic and prognostic marker for lung adenocarcinoma
by: Wei-qin Wu, et al.
Published: (2024-12-01) -
Plasma anti-PRTN3 IgG and IgM autoantibodies: novel biomarkers for early detection of lung adenocarcinoma
by: Yutong Li, et al.
Published: (2025-02-01) -
A comprehensive prognostic and immunological implications of Gremlin 1 in lung adenocarcinoma
by: Hongyan Li, et al.
Published: (2025-02-01)